A Short Of Review On Pancreatic β- Cell Function In Diabetes Mellitus Patients

Authors

  • Hariballav Mahapatra
  • Jaydeep Kumar Sahu
  • Akanksha Pandey
  • Danish Javed
  • Ramya.P
  • Dinesh Tripathi

Keywords:

T2D, β- cell DF, Inflammatory Response,, CRP, TNF-α

Abstract

According to a study, IR & β-cell DF are involved in the onset and advancement of T2D. In addition to the harmful consequences of IR, IFM & OS have become significant characteristics that delineate β-cell DF. Key inflammatory markers, including CRP, TNF-α and IL-1β linked to β-cell DF in preclinical models. These effects demonstrate a PAT association between an aberrant IFM response and the production of OS in the advancement of T2D. Therefore, in this review we have discussed about the normal function and pathological aspect of β- cell.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Dludla PV, Mabhida SE, Ziqubu K, Nkambule BB, Mazibuko-Mbeje SE, Hanser S, Basson AK, Pheiffer C, Kengne AP. Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress. World journal of diabetes. 2023 Mar 15;14(3):130.

Dludla PV, Mabhida SE, Ziqubu K, Nkambule BB, Mazibuko-Mbeje SE, Hanser S, Basson AK, Pheiffer C, Kengne AP. Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress. World journal of diabetes. 2023 Mar 15;14(3):130.

Cerf ME. Beta cell dysfunction and insulin resistance. Frontiers in endocrinology. 2013 Mar 27;4:37.

Saisho Y. β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes. World journal of diabetes. 2015 Feb 15;6(1):109.

Do OH, Gunton JE, Gaisano HY, Thorn P. Changes in beta cell function occur in prediabetes and early disease in the Lepr db mouse model of diabetes. Diabetologia. 2016 Jun;59:1222-30.

Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system?. Diabetologia. 1998 Sep;41:1241-8.

Lontchi-Yimagou E, Sobngwi E, Matsha TE, Kengne AP. Diabetes mellitus and inflammation. Current diabetes reports. 2013 Jun;13(3):435-44.

Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022 Jan 11;55(1):31-55.

Singh RG, Yoon HD, Wu LM, Lu J, Plank LD, Petrov MS. Ectopic fat accumulation in the pancreas and its clinical relevance: a systematic review, meta-analysis, and meta-regression. Metabolism. 2017 Apr 1;69:1-3.

Lei XG, Vatamaniuk MZ. Two tales of antioxidant enzymes on β cells and diabetes. Antioxidants & redox signaling. 2011 Feb 1;14(3):489-503.

Wang J, Wang H. Oxidative stress in pancreatic beta cell regeneration. Oxidative medicine and cellular longevity. 2017;2017(1):1930261.

Kahn SE, Chen YC, Esser N, Taylor AJ, van Raalte DH, Zraika S, Verchere CB. The β cell in diabetes: integrating biomarkers with functional measures. Endocrine reviews. 2021 Oct 1;42(5):528-83.

Itoh N, Okamoto H. Translational control of proinsulin synthesis by glucose. Nature. 1980 Jan 3;283(5742):100-2.

Alarcon C, Verchere CB, Rhodes CJ. Translational control of glucose-induced islet amyloid polypeptide production in pancreatic islets. Endocrinology. 2012 May 1;153(5):2082-7.

Martin SK, Carroll R, Benig M, Steiner DF. Regulation by glucose of the biosynthesis of PC2, PC3 and proinsulin in (ob/ob) mouse islets of Langerhans. FEBS letters. 1994 Dec 19;356(2-3):279-82.

Greenman IC, Gomez E, Moore CE, Herbert TP. The selective recruitment of mRNA to the ER and an increase in initiation are important for glucose-stimulated proinsulin synthesis in pancreatic β-cells. Biochemical Journal. 2005 Oct 15;391(2):291-300.

Verchere CB, D'Alessio DA, Prigeon RL, Hull RL, Kahn SE. The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells. Diabetes. 2000 Sep 1;49(9):1477-84.

Gasa R, Gomis R, Casamitjana R, Novials A. High glucose concentration favors the selective secretion of islet amyloid polypeptide through a constitutive secretory pathway in human pancreatic islets. Pancreas. 2001 Apr 1;22(3):307-10.

Chen YC, Mains RE, Eipper BA, Hoffman BG, Czyzyk TA, Pintar JE, Verchere CB. PAM haploinsufficiency does not accelerate the development of diet-and human IAPP-induced diabetes in mice. Diabetologia. 2020 Mar;63:561-76.

Zhu X, Orci L, Carroll R, Norrbom C, Ravazzola M, Steiner DF. Severe block in processing of proinsulin to insulin accompanied by elevation of des-64, 65 proinsulin intermediates in islets of mice lacking prohormone convertase 1/3. Proceedings of the National Academy of Sciences. 2002 Aug 6;99(16):10299-304.

Capozzi ME, Svendsen B, Encisco SE, Lewandowski SL, Martin MD, Lin H, Jaffe JL, Coch RW, Haldeman JM, MacDonald PE, Merrins MJ. β Cell tone is defined by proglucagon peptides through cAMP signaling. JCI insight. 2019 Mar 7;4(5):e126742.

Khan R, Tomas A, Rutter GA. Effects on pancreatic Beta and other Islet cells of the glucose-dependent insulinotropic polypeptide. Peptides. 2020 Mar 1;125:170201.

Van Der Meulen T, Donaldson CJ, Cáceres E, Hunter AE, Cowing-Zitron C, Pound LD, Adams MW, Zembrzycki A, Grove KL, Huising MO. Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion. Nature medicine. 2015 Jul;21(7):769-76.

Wondmkun YT. Obesity, insulin resistance, and type 2 diabetes: associations and therapeutic implications. Diabetes, Metabolic Syndrome and Obesity. 2020 Oct 9:3611-6.

Dludla PV, Nkambule BB, Jack B, Mkandla Z, Mutize T, Silvestri S, Orlando P, Tiano L, Louw J, Mazibuko-Mbeje SE. Inflammation and oxidative stress in an obese state and the protective effects of gallic acid. Nutrients. 2018 Dec 21;11(1):23.

Böni-Schnetzler M, Meier DT. Islet inflammation in type 2 diabetes. InSeminars in immunopathology 2019 Jul 1 (Vol. 41, pp. 501-513). Springer Berlin Heidelberg.

Cerf ME. Beta cell physiological dynamics and dysfunctional transitions in response to islet inflammation in obesity and diabetes. Metabolites. 2020 Nov 10;10(11):452.

Tsalamandris S, Antonopoulos AS, Oikonomou E, Papamikroulis GA, Vogiatzi G, Papaioannou S, Deftereos S, Tousoulis D. The role of inflammation in diabetes: current concepts and future perspectives. European cardiology review. 2019 Apr;14(1):50.

Pfützner A, Standl E, Strotmann HJ, Schulze J, Hohberg C, Lübben G, Pahler S, Schöndorf T, Forst T. Association of high-sensitive C-reactive protein with advanced stage β-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus. Clinical Chemistry and Laboratory Medicine (CCLM). 2006 May 1;44(5):556-60.

PrayGod G, Filteau S, Range N, Kitilya B, Kavishe BB, Ramaiya K, Jeremiah K, Rehman AM, Changalucha J, Olsen MF, Andersen AB. β‐cell dysfunction and insulin resistance in relation to pre‐diabetes and diabetes among adults in north‐western Tanzania: a cross‐sectional study. Tropical Medicine & International Health. 2021 Apr;26(4):435-43.

Ndevahoma F, Nkambule BB, Dludla PV, Mukesi M, Natanael KN, Nyambuya TM. The effect of underlying inflammation on iron metabolism, cardiovascular risk and renal function in patients with type 2 diabetes. EJHaem. 2021 Aug;2(3):357-65.

Daousi C, Casson IF, Gill GV, MacFarlane IA, Wilding JP, Pinkney JH. Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors. Postgraduate medical journal. 2006 Apr;82(966):280-4.

Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Frontiers in immunology. 2018 Apr 13;9:754.

Kaneko N, Kurata M, Yamamoto T, Morikawa S, Masumoto J. The role of interleukin-1 in general pathology. Inflammation and regeneration. 2019 Dec;39:1-6.

Sun W, Wu Y, Gao M, Tian Y, Qi P, Shen Y, Huang L, Shi L, Wang Y, Liu X. C-reactive protein promotes inflammation through TLR4/NF-κB/TGF-β pathway in HL-1 cells. Bioscience reports. 2019 Aug;39(8):BSR20190888.

Zhang L, Shen ZY, Wang K, Li W, Shi JM, Osoro EK, Ullah N, Zhou Y, Ji SR. C‐reactive protein exacerbates epithelial‐mesenchymal transition through Wnt/β‐catenin and ERK signaling in streptozocin‐induced diabetic nephropathy. The FASEB Journal. 2019 May;33(5):6551-63.

Downloads

Published

2025-05-13

How to Cite

1.
Mahapatra H, Sahu JK, Pandey A, Javed D, Ramya.P R, Tripathi D. A Short Of Review On Pancreatic β- Cell Function In Diabetes Mellitus Patients. J Neonatal Surg [Internet]. 2025May13 [cited 2025Oct.2];14(23S):292-6. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/5737

Issue

Vol. 14 No. 23S (2025): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.